Breast Cancer Therapeutics in Major Developed Markets to 2020

1
Breast Cancer Therapeutics in Major Developed
Markets to 2020
One-Stop Shop for Business Information
2
Summary
'Breast Cancer Therapeutics in Major Developed
Markets to 2020 - Approval of Novel Therapies to
Support Continued Dominance of HER2 Targeted
Drugs', which provides in-depth analysis of
breast cancer therapeutics market within the
eight major geographies of the US, Canada, the
top five geographies in Europe (the UK, France,
Germany, Spain and Italy) and Japan. The report
provides an estimation of market size for 2013,
along with market forecast until 2020. It also
covers disease epidemiology, treatment
algorithms, treatment patterns, in-depth analysis
of the pipeline, and deal analysis. The breast
cancer therapeutics market in the eight major
markets - The US, The UK, France, Germany, Spain,
Italy, Japan and Canada - was worth 9.2 billion
in 2013, and is expected to grow at a Compound
Annual Growth Rate (CAGR) of 5.1 to 13.1
billion by 2020. 
3
The US had the largest market in 2013, valued at
5.5 billion, equivalent to a global share of
59, followed by Japan with 871.5m or 9.4 and
Italy with 668.5m or 7.2. Canada had the lowest
market share and value of the leading eight at
2.9 and 268.4m, but is expected to witness
rapid growth over the forecast period with a CAGR
of 6.7. This will only be surpassed by Japan,
which is expected to witness growth at a CAGR of
6.9. Scope The report analyzes treatment usage
patterns, market characterization, pipeline
analysis and key licensing and co-development
deals in the breast cancer in the major developed
markets. The report includes - - Disease
overview, as well as treatment algorithms and
treatment usage patterns  
4

• Market size and forecast for the breast cancer
  market from 2012 to 2019
• - Major marketed products for breast cancer
  along with a heat map of product performance
• - In-depth pipeline analysis for global pipeline
  in breast cancer along
• with clinical trial failure rate analysis
• - Key drivers and restraints that have had and
  are expected to have a significant impact upon
  the market
• - Key licensing and co-development agreements
  that could have impact on growth trends
•  

5
Table Of Content

1. List of Tables
2. Breast Cancer Therapeutics in Major Developed
   Markets to 2020 - Introduction
3. Breast Cancer Therapeutics in Major Developed
   Markets to 2020 - Marketed Products
4. Breast Cancer Therapeutics in Major Developed
   Markets to 2020 - Pipeline Analysis
5. Breast Cancer Therapeutics in Major Developed
   Markets to 2020 - Market Forecast to 2020
6. Breast Cancer Therapeutics in Major Developed
   Markets to 2020 - Deals and Strategic
   Consolidations
7. Contact Us

6

• To know more
• Breast Cancer Therapeutics in Major Developed
  Markets to 2020

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com